Johnson & Johnson’s Phase 3 AMPLITUDE study demonstrates that the combination of niraparib and abiraterone acetate with prednisone significantly...

Tactile Medical presented two-month data from the largest randomized controlled trial on head and neck cancer-related lymphedema at the...

aTyr Pharma released interim Phase 2 data for efzofitimod, a potential treatment for systemic sclerosis-related interstitial lung disease (SSc-ILD)....

Corvus Pharmaceuticals released interim Phase 1 clinical trial data for soquelitinib, an oral ITK inhibitor, in patients with moderate...

Biomerica’s inFoods IBS test, a personalized dietary therapy for Irritable Bowel Syndrome (IBS), demonstrated statistically significant improvement in patient...

Dyne Therapeutics announced preclinical data showing its drug candidate, DYNE-302, improved muscle function in a mouse model of facioscapulohumeral...

Rectify Pharmaceuticals presented data on RTY-822, a positive functional modulator (PFM) targeting the ABCC6 membrane transporter, at the 2025...

In this interview with Dr. Seema Rajsingh, Executive Medical Director and Jarem Edwards, Clinical Scientist – Early Drug Development...

The global obesity epidemic has shifted from a public health issue to a fiercely competitive pharmaceutical frontier. With GLP-1...